-
公开(公告)号:EP2032168A1
公开(公告)日:2009-03-11
申请号:EP07795759.5
申请日:2007-06-04
IPC分类号: A61K39/395
CPC分类号: A61K31/337 , A61K31/436 , A61K31/7068 , A61K45/06 , A61K2300/00
摘要: The invention provides the use of a combination of an mTOR inhibitor and capecitabine in the treatment of cancer.